Therapy
Biotechnology
Medical
Dermira
$8.389876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-0.48%) Today
$0.00 (0.00%) As of 4:43 PM EDT after-hours
Why Robinhood?
You can buy or sell Dermira and other stocks, options, ETFs, and crypto commission-free!
About DERM
Dermira, Inc. Common Stock, also called Dermira, is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. Read More It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.
Employees
333
Headquarters
Menlo Park, California
Founded
2010
Market Cap
449.44M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
657.55K
High Today
$8.47
Low Today
$8.23
Open Price
$8.39
Volume
443.50K
52 Week High
$15.48
52 Week Low
$6.00
Collections
Therapy
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
2014 IPO
Price Paid on Robinhood
21% Lower
Right Now
52 Week Low
$6.00
Average Price Paid
$10.66
52 Week High
$15.48
Analyst Ratings
90%
of 10 ratings
Buy
90%
Hold
10%
Sell
0%
DERM Earnings
-$1.74
-$1.33
-$0.92
-$0.51
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 5, After Hours